Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01706003 · ClinicalTrials.gov registry record
The Utility of Telemedicine in the Management of Migraine
A clinical trial of Migraine Headaches, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT01706003: Completed study of Migraine Headaches, sponsored by University of Texas Southwestern Medical Center.
NCT01706003 is a study of Migraine Headaches that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 45 participants, below the 125-participant average among 4 other Migraine Headaches trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01706003, a study of Migraine Headaches, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.
Primary Outcome
Percentage of completed scheduled study visits for each group.
Conditions Studied
Study Locations (1)
Texas
- Universit of Texas Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-10 |
What the finished NCT01706003 record still lists
NCT01706003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 125-participant average among 4 other Migraine Headaches trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Migraine Headaches appearing as the primary indexed condition, and to 0 interventions.
NCT01706003 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01706003 about?
NCT01706003 is a clinical study titled "The Utility of Telemedicine in the Management of Migraine". Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.
What is the current status of trial NCT01706003?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2012-10. Estimated completion is 2018-10.
What conditions does trial NCT01706003 study?
This clinical trial studies the following conditions: Migraine Headaches.
Who is sponsoring clinical trial NCT01706003?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01706003 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headaches
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acute Migraine Treatment in the ED With Gepants
RECRUITING · Phase 4
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
COMPLETED · Phase 2
-
Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
COMPLETED · Phase 1
-
Set Point Acupuncture for Migraines Using a Digital Assistant
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia